Cargando…

Case Report – Short-term Bisphosphonate Use Associated Stress Fractures

INTRODUCTION: Long-term bisphosphonate use has been linked to an increased risk of pathological neck of femur fractures. CASE REPORT: We write concerning a patient who presented with the left hip pain following a low impact fall, which was diagnosed as a pathological left neck of femur fracture. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dadrewalla, Arshan J., Battle, Joseph, Anakwe, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Orthopaedic Research Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983371/
https://www.ncbi.nlm.nih.gov/pubmed/36874892
http://dx.doi.org/10.13107/jocr.2022.v12.i10.3376
Descripción
Sumario:INTRODUCTION: Long-term bisphosphonate use has been linked to an increased risk of pathological neck of femur fractures. CASE REPORT: We write concerning a patient who presented with the left hip pain following a low impact fall, which was diagnosed as a pathological left neck of femur fracture. This was a subtrochanteric stress fracture most frequently seen in patients who take bisphosphonate medications. A key point of difference in our patient is the length of time of bisphosphonate use. A further interesting point was the method of imaging used to diagnose this fracture whereby plain radiographs and computerized tomography imaging both did not show any acute fracture whereas only a magnetic resonance imaging (MRI) hip demonstrated this fracture. Surgical insertion of a prophylactic intramedullary nail was done to stabilize the fracture and reduce the risk of progression to a complete fracture. CONCLUSION: This case brings up multiple key points not reviewed previously such as the fact a fracture developed only 1 month after bisphosphonate use rather than months or years. These points suggest that there should be a low threshold for investigation (including MRI scanning) into potential pathological fractures and that bisphosphonate use should be a red flag to initiate these investigations regardless of length of use.